Evidence suggests that lithium can help treat and even prevent Alzheimer’s. Studies in an Alzheimer’s mouse model showed that treatment with AL001 prevented cognitive impairment, depression, and ...

In Alzheimer’s disease (AD), significant numbers of nerve cells in the brain die, affecting patients’ ability to remember things and to think clearly — resulting in confusion, behavioral changes and ...

ApoE4 Alzheimer’s Alliance launched as US advocacy group A new patient advocacy organization, the ApoE4 Alzheimer’s Alliance, has launched in the U.S., with a goal of helping advance both supportive ...

A second phase of this study will include biobank data from some 1,000 additional patients in Europe and the U.S, and it should be complete in the coming months, Diadem stated in the release. The test ...

There is no cure for Alzheimer’s Disease (AD), but some medications may help reduce the symptoms or slow progression of the disease. As AD progresses, brain cells die and the connections between them ...

Alzheimer’s News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for ...

There were also incidents when my mother spoke harshly to a stranger, and I gently told her that she needed to remember to be kind. She always accepted that information and reverted to her core ...

“In the care home, I really wanted Jelly Drops to tackle dehydration and also to be really fun and engaging and sort of a social tool in the care home as well,” Hornby said in a video interview with ...

Alzheimer’s disease (AD) is associated with a gradual decline in memory and mental ability, due to the accumulation and spread of damage in the brain. It is an irreversible condition, with symptoms ...

Rough start in trying for ‘more time’ Aducanumab’s path toward FDA review, and possible approval, has been rather unique and quite tumultuous. After early trial data indicated that aducanumab had an ...

The Phase 1b portion was a one-month ascending dose phase to assess its safety, tolerability, and pharmacological properties. In the Phase 2 efficacy portion, participants were randomly assigned ...

No cure has yet been discovered to alleviate that financial burden, but early diagnosis could save as much as $7.9 trillion in total medical and long-term care costs for individuals in the U.S., ...